CEO SUMMARY: Recent weeks brought many rumors about an impending deal between Laboratory Corporation of America and Dynacare. That speculation was ended last week when it was disclosed that LabCorp would pay about $685 million in cash, stock and assumed debt to acquire Dynacare. The acquisition also spells the end to Dynacareâs strategy developing lab […]
To access this post, you must purchase The Dark Report.